Colin Edwards discusses how novel Artificial Intelligence (AI) diagnostics and technology help in the delivery of good healthcare and research for pulmonary fibrosis. Colin describes how technology can be used for patients to perform tests remotely and automatically send data to their healthcare professionals.
Colin Edwards is Chief Scientific Officer and co-founder of patientMpower Ltd, an Irish digital healthcare company specializing in monitoring lung and kidney health. He is responsible for the development and implementation of the clinical and health economics evaluation program for patientMpower in respiratory (interstitial lung disease, post-lung transplantation, Covid19) and renal conditions (hemodialysis, post-kidney transplantation). Founded Merlin Consulting Ltd in 2015 to advise creators of digital health products and develop robust assessments of the impact of new technologies on patient outcomes. Colin was previously General Manager/Head of Medical Affairs at the Ireland affiliate of Boehringer Ingelheim. He is a member of the Institute of Directors in Ireland.